- Work address:
- Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
-
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
E-pub date: 1 Jan 2024Journal name: Nat Med
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer
E-pub date: 24 Oct 2023Journal name: Nature Communications
235TiP Hamlet.rt Trans: Prospective single-centre translational study evaluating liquid biomarkers of radiation response
E-pub date: 1 Oct 2023Journal name: Annals of Oncology
- Research Integrity Conflict of Interest Disclosure:
- Last revised:
- 18/11/2022
Company Active Research funding Ownership Royalty payments Commitment to carry out work for a fee Ad hoc reimbursed work Travel Gifts/ other Inivata Ltd. Yes No Yes Yes Yes No Yes No Mission Therapeutics Yes No Yes No No No No No Storm Therapeutics Yes No Yes No No No No No AstraZeneca No Yes No No No No No No